Respiratory Muscle Fatigue and Lower Extremity Muscle Oxygenation
ConditionCOPD
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-75
SponsorIstanbul Medipol University Hospital
About this trial
In our study, changes in vastus lateralis muscle oxygenation will be evaluated with the Moxy device, a functional infrared oxygen measurement device, during the inspiratory muscle fatigue protocol in COPD cases and the healthy control group.
Eligibility criteria
Qualifiers
Having a diagnosis of Stage 2-3 COPD according to the following clinical diagnostic criteria according to the American Thoracic and European Respiratory Societies (ATS-ERS).
Having been using the same medications for the last 4 weeks
Disqualifiers
Patients with severe comorbid diseases, unstable coronary artery disease, collagen vascular diseases and requiring high-flow oxygen therapy (˃ 3-4 L\min).
Presence of any vascular problem that may affect lower extremity muscle oxygenation
Presence of another respiratory system disease other than COPD
Patients who have had an acute COPD exacerbation in the last 4 weeks
Trial design
Treatments tested in this trial
- Respiratory muscle fatigue protocol
Treatment groups
30 Participants
are divided into 2 treatment groupsSponsors and collaborators
Istanbul Medipol University Hospital
Lead sponsor
Saglik Bilimleri Universitesi
Sponsor institution
Source ClinicalTrials.gov